UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015526
Receipt number R000018036
Scientific Title Examination of relationship between the expression of renin angiotensin system components and electrolyte channel-related protein in renal biopsy tissues, and the activity, severity, curative effect and prognosis of nephritis.
Date of disclosure of the study information 2014/10/24
Last modified on 2021/10/29 09:09:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of relationship between the expression of renin angiotensin system components and electrolyte channel-related protein in renal biopsy tissues, and the activity, severity, curative effect and prognosis of nephritis.

Acronym

Examination of the expression of renin angiotensin system components and electrolyte channel-related protein expression in nephritis.

Scientific Title

Examination of relationship between the expression of renin angiotensin system components and electrolyte channel-related protein in renal biopsy tissues, and the activity, severity, curative effect and prognosis of nephritis.

Scientific Title:Acronym

Examination of the expression of renin angiotensin system components and electrolyte channel-related protein expression in nephritis.

Region

Japan


Condition

Condition

kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Search of a novel marker of a curative effect and prognositic indicator in nephritis

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

renal function

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

Residual sample in renal biopsy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patient who is adaptation of a renal biopsy

Key exclusion criteria

The patient judged not to be adaptation of a renal biopsy by the doctor in attendance (one kidney, a bleeding tendency, etc. )

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hiromichi
Middle name
Last name Wakui

Organization

Yokohama City University Graduate School of Medicine

Division name

Cardiorenal Medicine

Zip code

236-0004

Address

3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa

TEL

045-787-2635

Email

hiro1234@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name Hiromichi
Middle name
Last name Wakui

Organization

Yokohama City University Graduate School of Medicine

Division name

Cardiorenal Medicine

Zip code

236-0004

Address

3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa

TEL

045-787-2635

Homepage URL


Email

hiro1234@yokohama-cu.ac.jp


Sponsor or person

Institute

The Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

donations for research

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama City University

Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa

Tel

+81457872635

Email

hiro1234@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 10 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2014 Year 05 Month 15 Day

Date of IRB

2014 Year 10 Month 24 Day

Anticipated trial start date

2014 Year 10 Month 24 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 10 Month 24 Day

Last modified on

2021 Year 10 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018036


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name